Heart failure management: Multidisciplinary care has intrinsic benefit above the optimization of medical care
Journal of Cardiac FailurePublished 1 June 2002
Kenneth McDonald, Mark Ledwidge, John Cahill, P. J. Quigley, B. Maurer, Bronagh Travers
Citations164
SJR quartileQ1
SJR score2.16
SNIP1.49
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
These data demonstrate for the first time the intrinsic benefit of MDC in the setting of protocol-driven, optimal medical management of HF, as the lowest reported rate for such a high-risk group, underlines the value of this approach to the management of heart failure.
Abstract
These data demonstrate for the first time the intrinsic benefit of MDC in the setting of protocol-driven, optimal medical management of HF. Moreover, the event rate of 7.8% at 3 months, as the lowest reported rate for such a high-risk group, underlines the value of this approach to the management of heart failure.
Keywords
Medicine
New England Journal of MedicineA Multidisciplinary Intervention to Prevent the Readmission of Elderly Patients with Congestive Heart Failure
2,336 Citations1995Michael W. Rich, Valerie Beckham +4 more
A nurse-directed, multidisciplinary intervention can improve quality of life and reduce hospital use and medical costs for elderly patients with congestive heart failure.
CirculationComparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure
1,244 Citations1999Milton Packer, Philip A. Poole‐Wilson +7 more
These findings indicate that patients with heart failure should not generally be maintained on very low doses of an ACE inhibitor (unless these are the only doses that can be tolerated) and suggest that the difference in efficacy between intermediate and high doses of a ACE inhibitor is likely to be very small.
The LancetEffects of a multidisciplinary, home-based intervention on planned readmissions and survival among patients with chronic congestive heart failure: a randomised controlled study
640 Citations1999Simon Stewart, John Marley +1 more
A home-based intervention has the potential to decrease the rate of unplanned readmissions and associated health-care costs, prolong event-free and total survival, and improve quality of life among patients with chronic CHF.
HeartCost effective management programme for heart failure reduces hospitalisation
409 Citations1998Charles Cline, Bo Israelsson +3 more
A management programme for patients with heart failure discharged after hospitalisation reduces health care costs and the need for readmission.
Annals of Internal MedicineThe Association between the Quality of Inpatient Care and Early Readmission
391 Citations1995Carol M. Ashton, David H. Kuykendall +3 more
This study sought to determine whether the quality of inpatient care was associated with unplanned readmission within 14 days in men discharged from a hospital stay for treatment of diabetes, chronic obstructive lung disease, or heart failure.
Journal of the American College of CardiologyTreatment of Patients Admitted to the Hospital With Congestive Heart Failure: Specialty-Related Disparities in Practice Patterns and Outcomes
250 Citations1997Steven E. Reís, Richard Holubkov +5 more
Involvement of a cardiologist in the care of patients admitted to the hospital with CHF is associated with increased use of diagnostic testing, longer hospital stays and improved clinical outcome, which substantiate practice guidelines that suggest a role for cardiologists in the Care of symptomatic patients withCHF.
Journal of Cardiac FailureHeart failure disease management: a critical review
242 Citations1999Michael W. Rich
Based on currently available data, heart failure disease management programs appear to be a cost-effective approach to reducing morbidity and enhancing quality of life in selected patients with heart failure.
Journal of the American College of CardiologyDifferences Between Primary Care Physicians and Cardiologists in Management of Congestive Heart Failure: Relation to Practice Guidelines 11This work was supported in part by unrestricted grants from Bristol-Myers Squibb Co., Princeton, New Jersey; Burroughs Wellcome Co., Research Triangle Park, North Carolina; Merck & Co., West Point, Pennsylvania; and the Department of Veterans Affairs Research Service.22All editorial decisions for this article, including selection of referees, were made by a Guest Editor. This policy applies to all articles with authors from the University of California in San Francisco.
226 Citations1997Martin E. Edep, Nihir B. Shah +2 more
Cardiologists report practices more in conformity with published guidelines for CHF than do internists and FP/GPs, and these differences may have a major impact on outcomes and health care costs.
Journal of Cardiac FailureWhich patients with heart failure respond best to multidisciplinary disease management?
113 Citations2000Bárbara Riegel, Beverly Carlson +2 more
An intervention of this type and intensity is recommended primarily for functional class II heart failure patients, and increases in cost in class I patients may have resulted from improved access to care.
The American Journal of CardiologyImpact of angiotensin-converting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failure
75 Citations1998Aileen B Luzier, Alan Forrest +4 more
Clinical usage of digoxin, diuretic, and angiotensin-converting enzyme (ACE) inhibitor was assessed in patients readmitted over a 36-month period for congestive heart failure, and readmission rates are lower when daily ACE inhibitor doses exceed 5 mg enalapril or the equivalent daily, but are unaffected by digoxin or diUREtic.
Journal of Cardiovascular PharmacologyDiffering Early Blood Pressure and Renin-Angiotensin System Responses to the First Dose of Angiotensin-Converting Enzyme Inhibitors in Congestive Heart Failure
41 Citations1996I B Squire, R J MacFadyen +3 more
The disparate blood pressure responses to perindopril and enalapril in CHF are confirmed and there is no evidence of slow, tight binding or steric hindrance to explain these differences.
Expert Opinion on PharmacotherapyCarvedilol in the treatment of chronic heart failure
7 Citations2001Gordon W. Moe
Experimental and clinical studies have confirmed carvedilol’s vasodilator, anti-oxidant and anti-apoptotic properties, which may contribute to its effect in reversing cardiac remodelling in animal models and patients with heart failure.